Form 8-K - Current report:
SEC Accession No. 0001663577-24-000257
Filing Date
2024-10-03
Accepted
2024-10-03 11:21:12
Documents
14
Period of Report
2024-10-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K skvi8k_100324.htm   iXBRL 8-K 22857
2 PRESS RELEASE, DATED OCTOBER 3, 2024 ex99_1v2.htm EX-99.1 17344
  Complete submission text file 0001663577-24-000257.txt   212631

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE skvi-20241003.xsd EX-101.SCH 3024
4 XBRL LABEL FILE skvi-20241003_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE skvi-20241003_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT skvi8k_100324_htm.xml XML 3349
Mailing Address 6320 S SANDHILL ROAD UNIT 9 LAS VEGAS NV 89120
Business Address 6320 S SANDHILL ROAD UNIT 9 LAS VEGAS NV 89120 702-433-7154
SKINVISIBLE, INC. (Filer) CIK: 0001085277 (see all company filings)

EIN.: 880344219 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25911 | Film No.: 241350366
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)